At Strand Life Sciences, she plays a key role in the medical genetics and genomics programs, with a strong focus on inherited rare disease and prenatal diagnostics. She oversees next-generation sequencing (NGS) based reporting, combining advanced genomic technologies with in-depth clinical interpretation to support accurate and timely diagnosis. Her work reflects the growing shift toward genomics-driven healthcare, where molecular insights are increasingly enabling earlier, more precise, and personalized diagnostic approaches reshaping the landscape of clinical medicine.

Beyond rare disease and prenatal genetics, Dr. Ganapathy is also deeply engaged in pharmacogenomics, consumer genomics, scientific curation, and the evolving field of precision medicine.

A CSIR fellow and gold medallist, she has authored and co-authored numerous peer-reviewed publications in leading international journals and is a regular contributor and speaker at national and global genomics forums.

At Strand Life Sciences, she plays a key role in the medical genetics and genomics programs, with a strong focus on inherited rare disease and prenatal diagnostics. She oversees next-generation sequencing (NGS) based reporting, combining advanced genomic technologies with in-depth clinical interpretation to support accurate and timely diagnosis. Her work reflects the growing shift toward genomics-driven healthcare, where molecular insights are increasingly enabling earlier, more precise, and personalized diagnostic approaches reshaping the landscape of clinical medicine.

Beyond rare disease and prenatal genetics, Dr. Ganapathy is also deeply engaged in pharmacogenomics, consumer genomics, scientific curation, and the evolving field of precision medicine.

A CSIR fellow and gold medallist, she has authored and co-authored numerous peer-reviewed publications in leading international journals and is a regular contributor and speaker at national and global genomics forums.